Market Overview

UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Accenture plc

Related ACN
TransCelerate BioPharma Awards Accenture New Clinical Data Sharing Services Contract
Accenture Establishing Centre for Innovation in Dublin; To Hire 200+ Professionals
The Vetr community has downgraded $ACN to 3-Stars (Vetr)

In a report published Wednesday, BMO Capital Markets reiterated its Market Perform rating on Accenture plc (NYSE: ACN), and raised its price target from $69.00 to $72.00.

BMO Capital Markets noted, “We think that Accenture continues to execute very well and gain share in both the consulting and outsourcing markets. We expect Accenture to have another strong bookings quarter in the Nov Q and think that bookings will be between $8.0 billion and $8.5 billion, and more likely closer to $8.5 billion...We retain our Market Perform rating on Accenture, held back by valuation. On a relative to S&P 500 basis, Accenture trades at a 1.23x S&P 500 NTM multiple, versus the last three-year average of 1.11x. Hence, while we think that Accenture is executing well in an uncertain tech spending environment, we believe its valuation is full at current levels.”

Accenture plc closed on Tuesday at $71.33.

Latest Ratings for ACN

Sep 2015BMO CapitalMaintainsMarket Perform
Sep 2015BarclaysMaintainsEqual-weight
Sep 2015Argus ResearchUpgradesHoldBuy

View More Analyst Ratings for ACN
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings


Related Articles (ACN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters